Tetra Bio-Pharma Inc.

Trending Articles

  1. Rousselot to spotlight holistic benefits of collagen peptides at Vitafoods Europe 2024 The company will highlight three new clinical studies that support new benefits concerning its PEPTAN collagen peptide brand
  2. Tereos unveils new Innovation Centre for European customers The novel centre brings newly established laboratories for the food, pharmaceutical and cosmetics industries, as well as upgraded analytical technologies
  3. Arla Foods Ingredients new beverage concept for nutrition-conscious gamers The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
  4. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  5. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Regulatory

Tetra Bio-Pharma files patent application for cannabis residue

If granted, this patent application will provide Tetra with protection for the use of cannabis plant residue material as an oral prebiotic component
Ingredients

Clinical study on cannabis oil capsules for patients suffering from chronic pain should be completed by autumn 2018

Tetra Bio-Pharma provides a status report on its encapsulated cannabis oils (PPP005) clinical trials and that these cannabis products are ready to commercialise in the retail market post-legalisation
Ingredients

Neptune and Tetra Bio-Pharma to develop purified cannabinoid oil-based products

Neptune Technologies & Bioressources and Tetra Bio-Pharma have entered into an agreement for the codevelopment, commercialisation and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets
Ingredients

Tetra Bio-Pharma and Santé Cannabis launches phase 4 cannabis oil trial

Tetra Bio-Pharma, a specialist in cannabinoid-based drug development and discovery, announced the launch of a medical cannabis oil programme, aiming to target the lucrative cannabis oil market and strengthen its plans to generate revenue from the medical cannabis market
Ingredients

Tetra Bio-Pharma announces acquisition of IP to develop natural health products through its Agro-Tek subsidiary

The company will be seeking to acquire additional product lines for distribution in North America
Subscribe now